Stage C: Symptomatic heart failure Class III: Marked limitation of physical activity The ACC/AHA system includes people who ...

Bayer’s AskBio unit has reported the first clinical data for its congestive heart failure gene therapy ... The results of the study – reported at the AHA annual congress – come from the ...

at the American Heart Association (AHA) 100th Annual Meeting 2024, the safety of glucagon-like peptide-1 receptor (GLP-1R) agonists in heart failure and chronic kidney disease (CKD) patients was ...